Steris Corp. disclosed in its quarterly annual report on Form 10-Q
filed with the U.S. Securities and Exchange Commission that on
Jan. 20, 2009, the Company announced that it submitted to the U.S.
Food and Drug Administration a new liquid…
provides in-depth news coverage of pending and recently settled lawsuits involving public companies with assets of USD $1 billion or more. Covered litigation topics include tax issues, insurance disputes, labor problems, shareholder suits, antitrust suits, product liability suits, toxic torts, personal injury suits, among others.